ticker,published_utc,title,publisher,url
IMVT,2025-11-12T10:07:27+00:00,"Immunovant, Inc. (IMVT) Q2 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=338df878b4356ddd172e4b8916f6522b25d3f3107d4b9b862bcaa423bc020124
IMVT,2025-11-10T12:31:39+00:00,"Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=718dbf391ade31cc763160d72d0379a3c1db2107f8c4c82ea12826bf4dd1059d
IMVT,2025-11-06T09:20:53+00:00,Viridian Therapeutics Is Ready For An Eventful 2026,SeekingAlpha,https://finnhub.io/api/news?id=d6b7ab77cb30e1140da8465ba89bf3435120cb9dc3a793c611a169b1bc553e52
IMVT,2025-11-03T05:08:36+00:00,Evaluating Immunovant (IMVT): Does Recent Momentum Signal a Premium Valuation?,Yahoo,https://finnhub.io/api/news?id=5387cd65bcc3f87bda71d6f40d87ce50513fe4d001468c741c05db99a2be2e99
IMVT,2025-10-31T14:03:53+00:00,Immunovant (IMVT) Soars 14.6% Ahead of Q3 Results,Yahoo,https://finnhub.io/api/news?id=91c26520b3804b0317b83b4188880358297a7588e0b200a34c4b7fd70978e56c
IMVT,2025-10-31T14:01:55+00:00,"Immunovant: Takeover Buzz, IMVT-1402 Promise, And Why I'm Staying Neutral",SeekingAlpha,https://finnhub.io/api/news?id=f2e05796424c6218fc7288ff1fef23753a19f09a81fbc8df8437d36b84752988
IMVT,2025-10-27T20:10:00+00:00,"Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025",Yahoo,https://finnhub.io/api/news?id=35188317b2333d4dffeb78b77e4ed2ef96b8c38b7aaf9616fba2bd5bea0898b1
IMVT,2025-10-08T04:57:07+00:00,JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37,Yahoo,https://finnhub.io/api/news?id=e508901e8563e5b63bda2b77ff2eb585ae6add9de96552e880cd915866ad37ee
IMVT,2025-09-30T08:00:56+00:00,Where is Immunovant (IMVT) Heading According to Analysts?,Yahoo,https://finnhub.io/api/news?id=2ab936bd29e5b752d1d78f311aa703f50bb38f47a08f352701806e7920aae7bb
IMVT,2025-09-15T20:21:09+00:00,Tracking Baker Brothers Portfolio - Q2 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=5e37726d20385b6bb93e958d1b62282047457155a26b30660631e4b49ed45e4b
IMVT,2025-09-11T11:46:51+00:00,Roivant Sciences (ROIV) Is Up 9.4% After Positive Immunovant Data and Japan Orphan Drug Nod - What's Changed,Yahoo,https://finnhub.io/api/news?id=99e98a4b74f1c16f7ab2a0fb345b883581077a828912409288864e0eaccca3c5
IMVT,2025-09-10T16:30:04+00:00,Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue?,Yahoo,https://finnhub.io/api/news?id=af45153083f357db8c96ea82c9fc46f0f5847d79e4baaafae6df9a101c094492
IMVT,2025-09-10T12:07:26+00:00,Immunovant (IMVT) Highlights New Graves’ Disease Data Can Its Pipeline Deliver Sustainable Innovation?,Yahoo,https://finnhub.io/api/news?id=a4f43650a07d1372eb62131edb5a0c9e6740cd6bd9cb2283493303bc419a05eb
IMVT,2025-09-09T12:51:03+00:00,A Look at Immunovant's Valuation Following New Batoclimab Data Update for Graves' Disease,Yahoo,https://finnhub.io/api/news?id=0bfdff210ebd1aadb6b19beb95319bacd64d5f4163f759512e9450f4d90abc08
IMVT,2025-09-04T16:36:45+00:00,"Immunovant's New Data Shows Batoclimab's Potential to Replace Current Graves' Disease Options, Oppenheimer Says",Yahoo,https://finnhub.io/api/news?id=f1f25f5903841705454a8276b51a8c46546d5336a1c1c631710683020a210148
IMVT,2025-09-04T16:06:00+00:00,IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results,Yahoo,https://finnhub.io/api/news?id=52a06b01417c899751a00252a089425d03665f0b696c5d7244feec5c3913c9d2
IMVT,2025-09-03T23:17:17+00:00,Why Immunovant Stock Blasted Higher Today,Yahoo,https://finnhub.io/api/news?id=af829db2615cc9079e662f38f3e7c8c9b28e19f91a45d7a00eae164bec2b165f
IMVT,2025-09-03T19:27:34+00:00,Immunovant Reports 'Encouraging' Data on Graves' Disease Treatment; Shares Rise,Yahoo,https://finnhub.io/api/news?id=181ef55f9574e5fe9594aeefe2880521bb30c1d8c8d9a5899fa90c8d8be4588e
IMVT,2025-09-03T18:01:00+00:00,Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients,Yahoo,https://finnhub.io/api/news?id=9cdf476133fbb0a55bc6a26f497ec9c354c5ffc8c2b621f1b0aa5a512fe4d3ec
IMVT,2025-09-03T17:57:00+00:00,Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients,Yahoo,https://finnhub.io/api/news?id=8c2b29008877acec7d003ff73e24394f8c64a1fd83a2f210cce64f237c8eb6c2
IMVT,2025-08-29T03:49:50+00:00,Roivant Sciences (ROIV) Announces Q1 2025 Business Update,Yahoo,https://finnhub.io/api/news?id=0e3340e454f59d6000baa34808fd8de3afd5a706dc9a75f5830fadf526543a32
IMVT,2025-08-15T09:30:33+00:00,Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst Stack,SeekingAlpha,https://finnhub.io/api/news?id=56f04f04a1a85cd2b1e51e32ef9aec7715f0d5031f48f8a6848119e17127b124
IMVT,2025-08-12T14:26:00+00:00,"Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus",Yahoo,https://finnhub.io/api/news?id=c58aead35f0dafa52fddb4ad3b93042fa24908861b6cf82c8d3119ff61cb388d
IMVT,2025-08-11T11:00:00+00:00,"Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025",Yahoo,https://finnhub.io/api/news?id=3e92d739db69e055866ee6ee71751a22f13af359c0ef8680675771bdfe742c49
IMVT,2025-07-16T16:00:02+00:00,All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy,Yahoo,https://finnhub.io/api/news?id=3a158c42b335218023b78ad6ce880884768de7ebf0908865a4d6b03214a73d6a
IMVT,2025-07-16T13:55:03+00:00,Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High?,Yahoo,https://finnhub.io/api/news?id=b3522fb32f15ef7ae52619093fd3fd3960ce649c41e989c712eb3aa69e888f80
IMVT,2025-07-16T13:38:47+00:00,Goldman Sachs Resumes Coverage of Immunovant (IMVT) with a Hold Rating,Yahoo,https://finnhub.io/api/news?id=f903203f484e00e6b78c76976241b652e1cb36cb36684ad90a9c5faef048a54b
IMVT,2025-07-06T08:15:22+00:00,LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT,Yahoo,https://finnhub.io/api/news?id=cf6d73b4bdcee31dd4ab8ec98397ad86e48b3f855222558fbe3d4a3999642856
IMVT,2025-06-17T21:14:09+00:00,Tracking Baker Brothers Portfolio - Q1 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=888e169590425d0b04646e475e4a44c603e3ef61b4a9462821aeb378d6af90db
IMVT,2025-06-13T08:30:47+00:00,Immunovant: Navigating The Complexities Of The FcRn Landscape (Downgrade),SeekingAlpha,https://finnhub.io/api/news?id=932c060d3de781d0b13dcc5ed326f694500702864e060a487ab7249b9282977f
IMVT,2025-06-04T02:00:00+00:00,Tourlite Capital Q1 2025 Investor Letter,SeekingAlpha,https://finnhub.io/api/news?id=2a8426883e303c99125a37493f25f5a5c73cd57b231d26d76bb704c726581f68
IMVT,2025-06-02T16:00:07+00:00,Immunovant (IMVT) Upgraded to Buy: What Does It Mean for the Stock?,Yahoo,https://finnhub.io/api/news?id=c2a2273b6479889eca65c8da25335a2d70e2cc0245044e5c5ec8f50473f162d3
IMVT,2025-05-30T12:59:00+00:00,"IMVT Q4 Loss Narrower Than Expected, Stock Up, Pipeline in Focus",Yahoo,https://finnhub.io/api/news?id=1f41a01885c07ff8798986488db621c2a44ec10e1513ef8c87d27dc72666c25c
IMVT,2025-05-29T11:46:49+00:00,"Immunovant, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025",Finnhub,https://finnhub.io/api/news?id=7d257a030ebe456e9b8ae7ee8083344e480d9b4420dd6854196c3f9b78dbc175
IMVT,2025-05-29T11:00:00+00:00,"Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025",Yahoo,https://finnhub.io/api/news?id=9f669fb47e6284e8e7684a09f7a1cfeefb782a4fc2384d2ca06255fc00505b11
IMVT,2025-05-28T18:17:50+00:00,H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock,Yahoo,https://finnhub.io/api/news?id=746b4c8ad48db76af34a0d12b113a0c1f15b2e221ba0c3a7d980045c5f8624be
IMVT,2025-05-21T20:49:04+00:00,"IMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the Firm",Finnhub,https://finnhub.io/api/news?id=2d9094ab67b2590abcb83b08670f4cf1e7a609cdfaa4ccc03be9de388f2a51ef
IMVT,2025-05-09T13:02:34+00:00,"Is Immunovant, Inc. (IMVT) The Best Stock That Will Bounce Back?",Yahoo,https://finnhub.io/api/news?id=d6b3fd8cd15e5512a19aeaefee6fdceb2f3bf4c4566b9e14c23e73b3cdd10a98
IMVT,2025-05-09T08:02:18+00:00,Argenx Q1 Earnings: Less Than Perfect Report Gets Punished,SeekingAlpha,https://finnhub.io/api/news?id=810dc4be5bfe5fffe33822c9cffb6c0297d8d89b98583c4653ed306cc77bc346
IMVT,2025-05-06T15:05:00+00:00,"Transcript : Immunovant, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04",Finnhub,https://finnhub.io/api/news?id=1a12a4bba75b09466fdf675b7de9ad5277924d7732c8fc171eb885a6ea5298f2
IMVT,2025-04-21T20:08:44+00:00,"Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug",Yahoo,https://finnhub.io/api/news?id=be240603cea8bff6d859da0563498fe4aab65332c5a4f0d3e10d6beddbda4b18
IMVT,2025-04-21T14:18:44+00:00,"Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift",Yahoo,https://finnhub.io/api/news?id=72eb63ca18942e06b9d19b80a87ad66aab238b17467a1c9bbfb5b6ed1c6e9d50
IMVT,2025-04-21T11:00:00+00:00,Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402,Yahoo,https://finnhub.io/api/news?id=fa74630efe2fe8a7fe8cfdb2ed20db6c80ac2fbd837e4b9bbd9e6e1608b2b5ff
IMVT,2025-04-08T14:05:52+00:00,"Is Immunovant, Inc. (IMVT) the Best Low Cost Stock to Buy According to Billionaires?",Yahoo,https://finnhub.io/api/news?id=b25f8bb0b79df60405a83dbbee035857988aee3bfb549f300b1bb2b8b7358cf5
IMVT,2025-03-24T13:56:32+00:00,Argenx: The Magic May Be Already Priced In,SeekingAlpha,https://finnhub.io/api/news?id=0d2cee3752538f8b5993d1f1bf07d4f8c09a0f5d431d22d4713bb2b764bffc41
IMVT,2025-03-21T16:17:41+00:00,Immunovant price target raised to $61 from $58 at Stifel,Yahoo,https://finnhub.io/api/news?id=3bd790079ffecfcef9f38571b448ba3797e26be75620f3273abc85a5986b57fc
IMVT,2025-03-20T16:30:47+00:00,"Immunovant’s batoclimab shows ‘impressive’ efficacy in MG, says H.C. Wainwright",Yahoo,https://finnhub.io/api/news?id=b682128aacfaa6c5662c365d5ad5c332b9872855e1c657cf89f4b27ae8409afa
IMVT,2025-03-20T14:19:00+00:00,IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success,Yahoo,https://finnhub.io/api/news?id=42b40f59d289c78993668954de993f2cabbc957aed4a247670ce7de7fa6d3d76
IMVT,2025-03-20T09:05:00+00:00,Invesco Health Care Fund Q4 2024 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e
IMVT,2025-03-19T20:04:33+00:00,Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose.,Yahoo,https://finnhub.io/api/news?id=d90e5fefa4b6f0b23652fda9d9bf01560e9cb5d6058c12d1a6d4bf8712ce0799
IMVT,2025-03-19T17:12:38+00:00,"Immunovant will not seek approval for MG therapy, despite hitting endpoints",Yahoo,https://finnhub.io/api/news?id=192895244908aaf92ced0ebd48e7dbb93c4399a05b41c78215d5eae1a276c126
IMVT,2025-03-19T17:07:50+00:00,Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward,SeekingAlpha,https://finnhub.io/api/news?id=ede01e2890b795153db1e4b34765bfb8f05fc93cbd0b22831c1421d0fd7e788d
IMVT,2025-03-19T16:39:00+00:00,Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data,Yahoo,https://finnhub.io/api/news?id=12c5dfe12548f0b19037b18484799de9374a8a88a83abbbe1342b7ef415df74a
IMVT,2025-03-19T11:45:00+00:00,Immunovant claims study success for immune disease drug but holds off on submission,Yahoo,https://finnhub.io/api/news?id=b08e8a218d27d22c141ef6a0b6f7cf31185135cf274dd9196420ffbc48c2a34c
IMVT,2025-03-19T11:45:00+00:00,Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies,Yahoo,https://finnhub.io/api/news?id=97b2fc0ec1d464ca6cbe4bacf876a27c83bde8e420f3911210ef3d75532cbcf7
IMVT,2025-03-19T10:03:05+00:00,"Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT)",Finnhub,https://finnhub.io/api/news?id=5799164cef2cafe474ca23c9fc81492a811fc76fbe8305c8bc2db5d777a65777
IMVT,2025-03-19T08:12:26+00:00,Immunovant's muscle disorder treatment meets main goal in late-stage trial,Finnhub,https://finnhub.io/api/news?id=bdeda3736a8e41deae25ee73eb688ffbae71ec87cf28eac91489b3253d10f87e
IMVT,2025-03-18T20:32:00+00:00,"Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs",Yahoo,https://finnhub.io/api/news?id=66e12ff9f5808f504351eae93ab5fe7c3360184816bb196351a0750d19055063
IMVT,2025-03-18T16:32:35+00:00,"Immunovant to Host Investor Webcast at 8: 00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs",Finnhub,https://finnhub.io/api/news?id=9b86106c5db07cfe3c293549e1198a1d18cff1a2dd7286d7e4ebf1c21520fba2
IMVT,2025-03-12T15:30:12+00:00,Incyte (INCY) Up 2.6% Since Last Earnings Report: Can It Continue?,Yahoo,https://finnhub.io/api/news?id=edf5c2aabf1eba0212d48a5cf62f0c5a1ee84d30522692cb31c6120299f0a2bc
IMVT,2025-03-06T00:13:05+00:00,"Immunovant, Inc. (IMVT): Among The Stocks With At Least $30 Million In Insider Spending Recently",Yahoo,https://finnhub.io/api/news?id=70600b82a2aa43a731351bf2a0caebf75acc368fcf803f08bfb355f1d9b982cf
IMVT,2025-03-04T21:50:21+00:00,"Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity",Yahoo,https://finnhub.io/api/news?id=e9ecfba0e41f7d96b786c915fdd021f1cefdd078f0d264fab8854b7f4fc092b7
IMVT,2025-02-27T11:58:00+00:00,"argenx: Vyvgart's Sales Momentum Improves, Clinical Data Updates From A Key Competitor Imminent",SeekingAlpha,https://finnhub.io/api/news?id=4319fc9d51504036d7ee747be4f0430368b7da0bdeecedf214c73becd518831e
IMVT,2025-02-23T18:33:14+00:00,"Immunovant, Inc. (IMVT): the Most Oversold Pharma Stock to Buy According to Analysts",Yahoo,https://finnhub.io/api/news?id=dc3fb06f0200d524904666ab9c97d7cec1e0f693b5d2328e1482c42df2d2647a
IMVT,2025-02-22T05:53:03+00:00,"Immunovant, Inc. (IMVT): Is It The Most Oversold Healthcare Stock to Buy Now?",Yahoo,https://finnhub.io/api/news?id=af43a557e69e0ec5dfa2f041843d1bd530edc25a204ddd594d82008c4c2f9065
IMVT,2025-02-21T02:45:00+00:00,Tourlite Capital Q4 2024 Investor Letter,SeekingAlpha,https://finnhub.io/api/news?id=a555288116b01bc7cfbf7eeb485c6aab421823332372b56222bc81f4de99b8ab
IMVT,2025-02-19T21:49:34+00:00,"Immunovant, Inc. (IMVT): Among Stocks Insiders Spent The Most Money On Recently",Yahoo,https://finnhub.io/api/news?id=fab3339611b00b3a9a33274b7a874c64fac9b42f73b52d35779fe684bda71da2
IMVT,2025-02-12T15:00:39+00:00,Roivant Sciences price target lowered to $12 from $13 at BofA,Yahoo,https://finnhub.io/api/news?id=23c6b738d273112b2ae2d435f26c791bb3e4e5464fb9dbf8791e55af3c349e2f
IMVT,2025-02-12T14:35:06+00:00,"Immunovant (IMVT) Loses -15.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner",Yahoo,https://finnhub.io/api/news?id=e2f37732394c500f80039915941a3caadb1ffa949b3ac286a8e9a4874c8cdbab
IMVT,2025-02-11T04:57:11+00:00,Q3 2024 Roivant Sciences Ltd Earnings Call,Yahoo,https://finnhub.io/api/news?id=ebde2ac0cfd62dc18645db21ea81a6b775953ef9ec424593d4dbd782531a57bc
IMVT,2025-02-07T15:09:00+00:00,"IMVT Q3 Loss Wider Than Expected, Stock Down, Pipeline in Focus",Yahoo,https://finnhub.io/api/news?id=bb7efa96fb6432537e92495b9622293eb173edc6c570d18aaf23025a4e10f1cd
IMVT,2025-02-06T11:30:00+00:00,"Immunovant Reports Financial Results for the Quarter Ended December 31, 2024",Yahoo,https://finnhub.io/api/news?id=898b2996d24e10d37c2767c08a2485884c9c70e0ef2d3e30615c02d2e21b1e8c
IMVT,2025-01-24T13:35:05+00:00,"Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm",Finnhub,https://finnhub.io/api/news?id=540913a6b093279482ab827d101c007fb862b99d791ff498ff44fa9f02ac7fe5
IMVT,2025-01-13T08:01:56+00:00,Immunovant Announces $450 Million Private Placement,Finnhub,https://finnhub.io/api/news?id=189baf6c07ac477135a3be2cf29a757ab65d992478a352458f7d427532403931
IMVT,2024-12-30T15:17:57+00:00,We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth,Yahoo,https://finnhub.io/api/news?id=8f8d421963cb6769983d35653cf3dad7f076186859cec350cadb3787cc19136d
IMVT,2024-12-27T10:50:09+00:00,Immunovant: Continued FcRn Targeting With IMVT-1402 Pivotal Study,SeekingAlpha,https://finnhub.io/api/news?id=6386bcbe3a247bc43349281a4526128d00181973aca0d2ed1b53b429426b5c29
IMVT,2024-12-20T12:20:47+00:00,Immunovant price target lowered to $45 from $47 at Wells Fargo,Yahoo,https://finnhub.io/api/news?id=21f93806d02648012e217122cf55f27b7c63db0c9262e85b5315d2d4390721d3
IMVT,2024-11-21T22:31:40+00:00,"Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?",Yahoo,https://finnhub.io/api/news?id=934a23858addd5ef3c1d33d23c2626f2ca755f05c1b1aa06ba1c8b07258f1801
